Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats
Open Access
- 1 September 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 8 (9) , 1097-1101
- https://doi.org/10.1002/jbmr.5650080910
Abstract
An anabolic effect on bone of intermittent parathyroid hormone (PTH) treatment has been found in patients with osteoporosis and also in experimental animals. Controversies exist, however, about whether the positive effect on the trabecular bone balance occurs at the expense of the cortical bone. We examined the biomechanical quality of cortical bone after intermittent treatment with different doses of PTH and, furthermore, compared the effects of PTH-(1–34) and PTH-(1–84). Groups of rats were treated with biosynthetic human PTH-(1–34) or PTH-(1–84), 1.1, 3.3, 10, or 30 nmol/kg/day for 30 days. No changes in the body weights and no changes in the lengths of the femora were observed after the PTH treatments. The bio-mechanical properties were analyzed by means of a materials-testing machine. A dose-related increase in the bending strength and stiffness of the femora was found, and this increase in mechanical strength corresponds with a 9–12% increase in the cross-sectional area of the femoral diaphyses. The deflection capability and energy absorption were not influenced by any of the PTH treatments. No differences were found between the effects of PTH-(1–34) or PTH-(1–84) on the biomechanical properties of the femora. Consequently, intermittent treatment with biosynthetic PTH-(1–34) or PTH-(1–84) increased the formation of cortical bone, and the biomechanical competence of the femora was found to be preserved.Keywords
This publication has 21 references indexed in Scilit:
- Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormoneBone, 1991
- The Stimulating Effect of Growth Hormone on Fracture Healing Is Dependent on Onset and Duration of AdministrationClinical Orthopaedics and Related Research, 1991
- Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized ratsJournal of Bone and Mineral Research, 1990
- Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivoJournal of Bone and Mineral Research, 1989
- Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in ratsBone, 1989
- Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin DJournal of Bone and Mineral Research, 1986
- A two-receptor model for the action of parathyroid hormone on osteoblasts: A role for intracellular free calcium and cAMPCell Calcium, 1985
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.BMJ, 1980